Amedis-UE

What Amedis-UE does

Amedis-UE AG is a Swiss pharmaceutical company operating in the healthcare distribution sector, supplying pharmacies, drugstores, and paramedical product channels. It was founded in 2002 and operates within the Swiss domestic market, with its primary sites now anchored at Niederbipp, Puidoux, and Romanshorn following the January 2025 consolidation.

In January 2025, Amedis-UE AG was combined with Voigt AG and Voigt Industrie Service AG to form the Avosano Group under Avosano Holding AG. The resulting group is structured around two operating entities: Avosano AG, which handles pharmaceutical wholesale as the link between manufacturers and specialist retail pharmacies (delivering within a 2-hour window via state-of-the-art logistics centers), and Avosano Industrie Service AG, which provides prewholesale supply chain and market access services to pharmaceutical industrial partners. The go-to-market is sales-led, executed via a field "Aussendienst" team servicing specialist retailers and industrial partners across Switzerland.

Revenue mechanics are split between transaction-based wholesale distribution (margin on the physical distribution of medicines) and service-fee prewholesale arrangements with industrial partners (fees for logistics and market access solutions). The product surface contains no disclosed technology stack, software platform, API, or AI components in the source material; the moat is operational (logistics) and regulatory (Swiss pharmaceutical distribution licensing) rather than technology-led. Marketing is institutional and B2B, executed primarily through a multilingual corporate website (avosano.ch) covering German, French, and English.

Name

Amedis-UE

Legal name

Amedis-UE AG

Website

https://amedis.ch

Company type

Private

Founded year

2002

Operating status

Acquired

Headcount range

251–500 employees

Short description

Amedis-UE AG is a Swiss pharmaceutical logistics company that supplies medicines and paramedical products to pharmacies and pharmaceutical industry partners. In January 2025 it merged with Voigt AG and Voigt Industrie Service AG to form Avosano Holding AG.

Ownership category

akta.pro rank

Product category

Pharmaceutical Wholesale and Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

akta.pro secondary industries

Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA), Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

Keywords

• Pharmaceutical wholesale
• Pharmaceutical logistics
• Prewholesale services
• Pharmacy supply
• Medicine distribution

Headquarters

HQ city

Aarau

HQ country

Switzerland

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Wholesale: Avosano AG acts as a pharmaceutical wholesaler, supplying medicines from the pharmaceutical industry to specialist trade (retailers). Revenue is generated through the margin earned on the distribution of pharmaceutical products, facilitated by state-of-the-art logistics centers and a flexible delivery structure capable of supplying customers within 2 hours.
2. Prewholesale Services: Avosano Industrie Service AG operates as a prewholesale specialist, providing supply chain and market access services to industrial pharmaceutical partners and specialist retailers. Revenue is derived from service fees for prewholesale logistics, market distribution, and tailored solutions for industrial partners.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels1 record

Core offering

Amedis-UE AG was a Swiss pharmaceutical distribution company that supplied medicines from pharmaceutical manufacturers to specialist retail pharmacies (pharmacies, drugstores) and provided prewholesale services including market access and supply chain management to industrial pharmaceutical partners. Following the January 2025 consolidation into the Avosano Group, the operations continue through Avosano AG (wholesale to specialist trade) and Avosano Industrie Service AG (prewholesale for industrial partners), leveraging state-of-the-art logistics centers with 2-hour delivery capability across three Swiss sites.

Product overview

The Avosano Group (founded January 2025 by combining Amedis-UE AG, Voigt AG, and Voigt Industrie Service AG) operates as a single unified pharmaceutical supply chain services company with two distinct divisions: Avosano AG handles pharmaceutical wholesale distribution to specialist retailers, while Avosano Industrie Service AG provides prewholesale services for industrial market access. Both divisions share state-of-the-art logistics infrastructure and a flexible 2-hour delivery structure across Switzerland.

Differentiator

Problem solved

Functional benefit

Products and services

• Avosano AG – Pharmaceutical Wholesale Pharmaceutical wholesale business that serves as the link between the pharmaceutical industry and specialist retail trade, ensuring the supply of medicines to consumers through state-of-the-art logistics centers and a flexible delivery structure capable of 2-hour supply. Targeted at specialist pharmacies and healthcare retailers in Switzerland.
• Avosano Industrie Service AG – Prewholesale Services Prewholesale services provider enabling industrial pharmaceutical partners to access the Swiss market efficiently and securely, offering specialist retailers a wide range of high-quality, reliable, and efficient supply chain services. Targeted at pharmaceutical manufacturers and industrial partners.

Quantifiable outcome

• Pharmaceutical supply within 2 hours to customers from logistics centers

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Amedis-UE AGcoreOthers · 1 January 2025Amedis-UE AG was one of three founding entities that merged in January 2025 to form the Avosano Group. It contributed resources, know-how, infrastructure, and experience to create the combined pharmaceutical logistics holding. Avosano Group states it was 'founded in January 2025 by combining the resources, know-how, infrastructure and experience of Amedis-UE AG, Voigt AG and Voigt Industrie Service AG.' Amedis-UE AG is now part of the consolidated Avosano Group structure.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Celesio / McKesson Europe: European pharmaceutical distribution arm of McKesson, operating through Lloyds Pharmacy and the Galexis network. Provides a direct upstream benchmark for the Avosano Group's wholesale-plus-prewholesale service model.
• Noweda eG: German cooperative pharmaceutical wholesaler with strong retail-pharmacy focus, similar to Avosano's specialist retail trade customer base. Provides a useful benchmark on cost-to-serve and logistics economics in pharma wholesale.
• Phoenix Group: Europe's largest pharmaceutical wholesale group, operating across 29 countries including neighboring Germany. Phoenix provides the most relevant pan-European scale benchmark and competes for industrial pharma customers that also use Swiss distributors.
• Alliance Healthcare (Walgreens Boots Alliance): Pan-European pharma wholesale and distribution business owned by Walgreens Boots Alliance, parent of Galexis. Highly comparable in service mix (wholesale and prewholesale) and in serving specialist retail customers across Europe.
• Sanacorp eG: German pharmaceutical cooperative wholesaler serving independent pharmacies. Comparable business model to Avosano's specialist-retail wholesale, although operating only in Germany and not directly competing in Switzerland.

Direct peers

• Hänseler AG: Swiss pharmaceutical wholesaler with a long history of supplying medicines to Swiss pharmacies and hospitals. Highly comparable in geography, customer base and product mix to the Amedis-UE/Voigt businesses that now sit within Avosano.
• Galexis AG: Galexis is Switzerland's largest pharmaceutical wholesaler and the principal direct competitor to Avosano AG, supplying medicines to Swiss pharmacies with nationwide distribution. Both operate in Swiss pharma wholesale to specialist retail, making them the closest functional comp.

Regional players

• Dr. A. & L. Schmidgall GmbH & Co KG: Austrian pharmaceutical wholesaler serving the Austrian and parts of the broader DACH region. Comparable product mix and customer base to Avosano, though operating in a different (DACH but not Swiss) national market.
• Amino AG: Swiss logistics and distribution company with pharmaceutical wholesale activities. Comparable Swiss-based pharma logistics focus, though with a broader portfolio including cosmetics and consumer healthcare distribution.

Others

• Voigt AG / Voigt Industrie Service AG: Sister companies combined with Amedis-UE AG in January 2025 to form the Avosano Group. Voigt AG was a specialist pharma wholesaler and Voigt Industrie Service AG a prewholesale/industrial service provider with overlapping services and customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/AmedisUEag
• LinkedInlinkedin.com/company/amedis-ue-ag

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Amedis-UE